Skip to Content
 

News: Translational Research and Interventional Oncology Research Program

Study tracks incidence, timing of immunotherapy-related deaths

Thursday, September 13th, 2018

Vanderbilt-Ingram Cancer Center researchers have answered questions about the incidence and timing of rare but sometimes fatal reactions to the most widely prescribed class of immunotherapies.

Using light to fight GVHD

Tuesday, September 4th, 2018

Vanderbilt investigators have conducted a prospective multicenter study on how extracorporeal photopheresis works in treating chronic graft-versus-host disease (cGVHD) — a complication of bone marrow or stem cell transplant that occurs when donor cells attack the recipient.

A new target for lung cancer

Tuesday, August 21st, 2018

A recent study suggests that a transporter protein called xCT may be potential therapeutic target in lung cancer.

Grant bolsters kidney cancer immunotherapy research

Friday, May 11th, 2018

Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer.

Cancer immunotherapy drugs linked with more serious heart effects

Monday, March 12th, 2018

Vanderbilt University Medical Center investigators have identified a growing number of serious and sometimes fatal cases of heart problems among cancer patients treated with some forms of immunotherapy.

VICC study sheds new light on Von Hippel-Lindau syndrome

Monday, March 12th, 2018

A new study by W. Kimryn Rathmell, MD, PhD, and colleagues, reveals a gene mutation’s role in Von Hippel-Lindau syndrome, a genetically inherited disease which causes tumor growth in several organs.

Lovly earns scholarship grant for lung cancer research

Monday, March 12th, 2018

Christine Lovly, MD, PhD, assistant professor of Medicine, has received a $200,000 grant to support promising new research on lung cancer.

Awareness, education goal of new HPV initiative

Monday, March 12th, 2018

Ronald Alvarez, MD, chair of the Department of Obstetrics and Gynecology, has formed the HPV-Associated Cancer Consortium Vanderbilt (HPVACTIVE) program to raise awareness and provide community-wide education about HPV-associated cancers.

A new target for neuroblastoma

Friday, February 16th, 2018

A new study by Dai Chung, MD, and colleagues reports that a protein, called SIRT6, plays an important role in the growth of neuroblastoma and suggests that SIRT6 may be a target for new therapeutics for the disease.

Lung screening program continues to grow

Thursday, January 11th, 2018

Vanderbilt University Medical Center’s (VUMC) Lung Screening Program for patients at high risk for cancer recently reached a milestone, enrolling more than 700 patients and performing more than 1,000 CT screening examinations.

Next Page »